Antagonists of human FGF23, pharmaceutical compositions, medicines and kits comprising the same, and uses thereof
TW202629583APending Publication Date: 2026-07-16NOVO NORDISK AS
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114138947
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-11
- Filing Date
- 2025-10-09
- Publication Date
- 2026-07-16
Abstract
The present invention relates to novel hFGF23 antagonistic polypeptides and long-acting derivatives thereof, and their use in medicine and in particular for inhibiting hFGF23-induced signalling in patients in need thereof, such as patients suffering from hypophosphatemic disorders, such as X-linked hypophosphatemic rickets (XLH), as well as pharmaceutical compositions comprising such compounds.
Need to check novelty before this filing date? Find Prior Art